Salidroside Pre-Treatment Inhibits Hypertensive Renal Injury and Fibrosis Through Inhibiting Wnt/β-Catenin Pathway

pubmed: wnt1 2024-12-21

Summary:

CONCLUSION: Our experimental data demonstrate that SAL pre-treatment protects against Ang II-induced hypertensive renal injury and fibrosis by suppressing the Wnt/β-catenin pathway in vivo and in vitro.

Link:

https://pubmed.ncbi.nlm.nih.gov/39506979/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=16uwQpOeqFYN8R4TKOtwPy2utpqy9ex2oldalD2yF_fQHv2caq&fc=None&ff=20241221063825&v=2.18.0.post9+e462414

From feeds:

Exome » pubmed: wnt1

Authors:

Jie Zhu, Liang Li, Yuting Luan, Ziqing Zhang, Yi Wang, Zhenyu Xu

Date tagged:

12/21/2024, 06:38

Date published:

11/07/2024, 06:00